Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louise Marquart

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
The Journal of Pathology|October 15, 2013
Metastatic progression of breast cancer: insights from 50 years of autopsiesMargaret C Cummings, Peter T Simpson, Lynne E Reid, et al.
European Journal of Nutrition|September 10, 2020
Omega-3 fatty acid intake and decreased risk of skin cancer in organ transplant recipientsKyoko Miura, Mandy Way, Zainab Jiyad, et al.
Malaria Journal|February 17, 2021
Development and evaluation of a new Plasmodium falciparum 3D7 blood stage malaria cell bank for use in malaria volunteer infection studiesStephen D Woolley, Melissa Fernandez, Maria Rebelo, et al.
The Lancet. Infectious Diseases|October 29, 2021
Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection studyJames S McCarthy, Özkan Yalkinoglu, Anand Odedra, et al.
Gynecologic Oncology|December 3, 2014
Incidence, risk factors and estimates of a woman's risk of developing secondary lower limb lymphedema and lymphedema-specific supportive care needs in women treated for endometrial cancerVanessa L Beesley, Ingrid J Rowlands, Sandi C Hayes, et al.
International Journal of Epidemiology|August 12, 2024
Use of an emulated trial to investigate the association between use of nitrogen-based bisphosphonates and risk of epithelial ovarian cancerKaren M Tuesley, Katrina Spilsbury, Penelope M Webb, et al.
Plos Medicine|August 22, 2020
Safety and parasite clearance of artemisinin-resistant Plasmodium falciparum infection: A pilot and a randomised volunteer infection study in AustraliaRebecca E Watts, Anand Odedra, Louise Marquart, et al.
Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies|July 27, 2011
CHEK2, MGMT, SULT1E1 and SULT1A1 polymorphisms and endometrial cancer riskTracy A O'Mara, Kaltin Ferguson, Paul Fahey, et al.
Molecular Carcinogenesis|December 5, 2013
Consequences of germline variation disrupting the constitutional translational initiation codon start sites of MLH1 and BRCA2: Use of potential alternative start sites and implications for predicting variant pathogenicityMichael T Parsons, Phillip J Whiley, Jonathan Beesley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2023
Characterizing the Blood-Stage Antimalarial Activity of Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparumBridget E Barber, Azrin N Abd-Rahman, Rebecca Webster, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
The Journal of Pathology|October 15, 2013
Metastatic progression of breast cancer: insights from 50 years of autopsiesMargaret C Cummings, Peter T Simpson, Lynne E Reid, et al.
European Journal of Nutrition|September 10, 2020
Omega-3 fatty acid intake and decreased risk of skin cancer in organ transplant recipientsKyoko Miura, Mandy Way, Zainab Jiyad, et al.
Malaria Journal|February 17, 2021
Development and evaluation of a new Plasmodium falciparum 3D7 blood stage malaria cell bank for use in malaria volunteer infection studiesStephen D Woolley, Melissa Fernandez, Maria Rebelo, et al.
The Lancet. Infectious Diseases|October 29, 2021
Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection studyJames S McCarthy, Özkan Yalkinoglu, Anand Odedra, et al.
Gynecologic Oncology|December 3, 2014
Incidence, risk factors and estimates of a woman's risk of developing secondary lower limb lymphedema and lymphedema-specific supportive care needs in women treated for endometrial cancerVanessa L Beesley, Ingrid J Rowlands, Sandi C Hayes, et al.
International Journal of Epidemiology|August 12, 2024
Use of an emulated trial to investigate the association between use of nitrogen-based bisphosphonates and risk of epithelial ovarian cancerKaren M Tuesley, Katrina Spilsbury, Penelope M Webb, et al.
Plos Medicine|August 22, 2020
Safety and parasite clearance of artemisinin-resistant Plasmodium falciparum infection: A pilot and a randomised volunteer infection study in AustraliaRebecca E Watts, Anand Odedra, Louise Marquart, et al.
Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies|July 27, 2011
CHEK2, MGMT, SULT1E1 and SULT1A1 polymorphisms and endometrial cancer riskTracy A O'Mara, Kaltin Ferguson, Paul Fahey, et al.
Molecular Carcinogenesis|December 5, 2013
Consequences of germline variation disrupting the constitutional translational initiation codon start sites of MLH1 and BRCA2: Use of potential alternative start sites and implications for predicting variant pathogenicityMichael T Parsons, Phillip J Whiley, Jonathan Beesley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2023
Characterizing the Blood-Stage Antimalarial Activity of Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparumBridget E Barber, Azrin N Abd-Rahman, Rebecca Webster, et al.
Pageof 9